[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4969 followers
Created: 2025-07-14 18:57:45 UTC

🦉 Low doses and early discontinuation drive weaker outcomes. Only patients who stayed on full doses (2.4 mg semaglutide, XX mg tirzepatide) matched trial-level weight loss. 
#obesity #GLP1 $NVO $LLY


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944833716280238440/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[weight loss](/topic/weight-loss)
[$mngl](/topic/$mngl)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)

[Post Link](https://x.com/AponiaAnalytics/status/1944833716280238440)